Alpex BioCleanse, Biotech Stock Review

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc. Our favorite...
American Brivision

Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List. $7.00 Price Potential.

Adding to Our 2020 Biotech 5-Pack, 5 Stocks We Expect to Double in 2020

Robinhood and Robindhoodette.

The New Force on Wall Street. It's not hedge funds, it's not program traders or AI-powered portfolio managers....

Stand Down IX: Is the Country Headed Into a Global Depression? Ray Dalio.

Q: Do you think we're headed into a global depression? A: Well, yes, but I want to be careful....
Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one...

Athersys (ATHX) Overview and Due Diligence links (Reddit)

I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are...
Internet Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:

Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz Don't Be That Guy in Denial!

Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy...
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...

Latest article

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.

Video: 2020 Year of Crisis: Markets Melt Up (Bloomberg). Ask Yourself a Question, Do I Feel...
Biotech Stock Review, Aphex BioCLeanse

Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.

Former Eastman Kodak Scientist Engineers Develop Liquid Germ Killer Hy-IQ™ Water to Revolutionize how Deadly Bacteria and Virus are Eradicated